Chemed CHE
$
Relative Strength Index (RSI)
- The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. It is typically used to identify overbought or oversold conditions in financial markets.
- The RSI is calculated using the following formula:
RSI = 100 - (100 / (1 + RS))
Where RS is the ratio of the average gains to the average losses over a specified period.
- The default time period used is 14 days.
- RSI values range between 0 and 100.
RSI values above 70 are considered overbought (indicating a potentially opportune time to sell)
RSI values below 30 are considered oversold (indicating a potentially opportune time to buy)
RSI is not a perfect indicator and should be used in conjunction with other technical analysis tools, this is for informational purposes only and is not a substitute for professional financial advice.
Key Insights
Chemed (CHE) Core Market Data and Business Metrics
Latest Closing Price
$618.56Price-Earnings Ratio
31.10Total Outstanding Shares
14.64 Million SharesDividend
$0.50 Per Share QuarterlySIC Description
Services-home Health Care ServicesPrimary Exchange
New York Stock ExchangeHeadquarters
Suite 2600, Cincinnati, OH, 45202
Historical Stock Splits
If you bought 1 share of CHE before May 12, 2005, you'd have 2 shares today.
| Execution Date | Split Amount |
|---|---|
| May 12, 2005 | 2-for-1 |
Short Interest
Track Short Interest Levels to Gauge Bearish Market Sentiment and Short Squeeze Potential
| Avg Daily Volume | Days to Cover | Settlement Date | Short Interest |
|---|---|---|---|
| 120,150 Shares | 2.41 | 3/14/2025 | 289,438 Shares |
| 123,836 Shares | 2.4 | 2/28/2025 | 296,729 Shares |
| 73,188 Shares | 4.28 | 2/14/2025 | 313,580 Shares |
| 104,509 Shares | 2.83 | 1/31/2025 | 295,474 Shares |
| 84,150 Shares | 3.3 | 1/15/2025 | 277,292 Shares |
| 117,336 Shares | 2.35 | 12/31/2024 | 276,015 Shares |
Cash Flow Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Net Cash Flow, Continuing | $-85.61 Million |
| Net Cash Flow From Operating Activities | $417.50 Million |
| Net Cash Flow From Operating Activities, Continuing | $417.50 Million |
| Net Cash Flow From Investing Activities | $-143.91 Million |
| Net Cash Flow From Investing Activities, Continuing | $-143.91 Million |
| Net Cash Flow | $-85.61 Million |
Income Statement
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Common Stock Dividends | $1.80 |
| Basic Average Shares | $15.02 Million |
| Income Tax Expense/Benefit | $97.47 Million |
| Selling, General, and Administrative Expenses | $424.36 Million |
| Net Income/Loss Attributable To Parent | $302.00 Million |
| Income/Loss From Continuing Operations Before Tax | $399.46 Million |
Comprehensive Income
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Comprehensive Income/Loss | $302.00 Million |
| Comprehensive Income/Loss Attributable To Parent | $302.00 Million |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0 |
| Other Comprehensive Income/Loss | $0 |
Balance Sheet
January 1, 2024 to December 31, 2024
| Metric | Value |
|---|---|
| Other Current Liabilities | $149.48 Million |
| Other Non-current Assets | $980.78 Million |
| Fixed Assets | $200.84 Million |
| Inventory | $8.19 Million |
| Noncurrent Liabilities | $263.89 Million |
| Equity | $1.12 Billion |
Historical Dividends
Current dividend: $0.50 Per Share Quarterly
| Announcement Date | Payment Date | Record Date | Amount | Frequency |
|---|---|---|---|---|
| Feb 14, 2025 | Mar 14, 2025 | Feb 24, 2025 | $0.5 | Quarterly |
| Nov 8, 2024 | Dec 6, 2024 | Nov 18, 2024 | $0.5 | Quarterly |
| Aug 2, 2024 | Aug 30, 2024 | Aug 12, 2024 | $0.5 | Quarterly |
| May 20, 2024 | Jun 18, 2024 | May 30, 2024 | $0.4 | Quarterly |
| Feb 16, 2024 | Mar 15, 2024 | Feb 26, 2024 | $0.4 | Quarterly |
| Nov 3, 2023 | Dec 4, 2023 | Nov 13, 2023 | $0.4 | Quarterly |